Moraya, Amani Ali, Jennifer Samadder, Pranati Liang, Lisa Morrison, Ludivine Werbowetski-Ogilvie, Tamra Ogunsina, Makanjuola Schweizer, Frank Arthur, Gilbert Nachtigal, Mark Additional file 6: Figure S5. of Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells Dose–response curves for COV362 cells and three primary HGSOC patient samples (EOC146, EOC183A, EOC183I) to GLN (open circle) or MO-101 (closed diamond). Intersections with the dashed line approximates the CC50 value. Drug doses where there is a significant difference in cell viability between culture conditions or treatments are indicated by an asterisk (*), p < 0.05. Ovarian cancer;Drug-resistance;Glycosylated anti-tumour ether lipid;Spheroid 2017-05-12
    https://springernature.figshare.com/articles/journal_contribution/Additional_file_6_Figure_S5_of_Novel_glycolipid_agents_for_killing_cisplatin-resistant_human_epithelial_ovarian_cancer_cells/5004353
10.6084/m9.figshare.c.3778562_D6.v1